GenVivo, Inc.
Jennifer Del Valle is currently a Biomanufacturing Scientist at GenVivo, Inc. Jennifer previously worked as a Research Assistant in Infectious Diseases at Children's Hospital Los Angeles. Jennifer holds a postgraduate degree in Clinical Laboratory Science/Medical Technology/Technologist from California State University-Dominguez Hills, a degree in Molecular, Cell and Developmental Biology, Microbiology, and Immunology from the University of California, Santa Cruz, and an Associate of Science degree in Biology/Biological Sciences from Long Beach City College.
GenVivo, Inc.
GenVivo was founded on the idea that we can effectively treat cancer patients with the latest gene delivery technologies. We are committed to enhancing the overall patient treatment experience. We deliver innovative drugs to empower the patient’s own immune system to mount a targeted attack against cancer. These therapies are off-the-shelf and come without the cost and time delays associated with personalized cancer vaccines. We are dedicated to providing accessible and efficient solutions that redefine the landscape of cancer treatment.